These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18593294)

  • 1. Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels.
    Nagot N; Ouedraogo A; Konate I; Weiss HA; Foulongne V; Defer MC; Sanon A; Becquart P; Segondy M; Sawadogo A; Van de Perre P; Mayaud P;
    J Infect Dis; 2008 Jul; 198(2):241-9. PubMed ID: 18593294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes.
    LeGoff J; Weiss HA; Gresenguet G; Nzambi K; Frost E; Hayes RJ; Mabey DC; Malkin JE; Mayaud P; Belec L
    AIDS; 2007 Jul; 21(12):1569-78. PubMed ID: 17630552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.
    Nagot N; Ouédraogo A; Foulongne V; Konaté I; Weiss HA; Vergne L; Defer MC; Djagbaré D; Sanon A; Andonaba JB; Becquart P; Segondy M; Vallo R; Sawadogo A; Van de Perre P; Mayaud P;
    N Engl J Med; 2007 Feb; 356(8):790-9. PubMed ID: 17314338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes Simplex Virus Type-2 Cervicovaginal Shedding Among Women Living With HIV-1 and Receiving Antiretroviral Therapy in Burkina Faso: An 8-Year Longitudinal Study.
    Low AJ; Nagot N; Weiss HA; Konate I; Kania D; Segondy M; Meda N; van de Perre P; Mayaud P;
    J Infect Dis; 2016 Mar; 213(5):731-7. PubMed ID: 26475931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial.
    Mayaud P; Legoff J; Weiss HA; Grésenguet G; Nzambi K; Bouhlal H; Frost E; Pépin J; Malkin JE; Hayes RJ; Mabey DC; Bélec L;
    J Infect Dis; 2009 Jul; 200(2):216-26. PubMed ID: 19530940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2.
    LeGoff J; Roques P; Jenabian MA; Charpentier C; Brochier C; Bouhlal H; Gresenguet G; Frost E; Pepin J; Mayaud P; Belec L;
    Clin Microbiol Infect; 2015 Sep; 21(9):873.e1-9. PubMed ID: 26003280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type 2 (HSV-2) genital shedding in HSV-2-/HIV-1-co-infected women receiving effective combination antiretroviral therapy.
    Péré H; Rascanu A; LeGoff J; Matta M; Bois F; Lortholary O; Leroy V; Launay O; Bélec L;
    Int J STD AIDS; 2016 Mar; 27(3):178-85. PubMed ID: 25769886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy.
    Tobian AA; Grabowski MK; Serwadda D; Newell K; Ssebbowa P; Franco V; Nalugoda F; Wawer MJ; Gray RH; Quinn TC; Reynolds SJ;
    J Infect Dis; 2013 Sep; 208(5):839-46. PubMed ID: 23812240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus type 2, genital ulcers and HIV-1 disease progression in postpartum women.
    Roxby AC; Drake AL; John-Stewart G; Brown ER; Matemo D; Otieno PA; Farquhar C
    PLoS One; 2011; 6(5):e19947. PubMed ID: 21637835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial.
    Ouedraogo A; Nagot N; Vergne L; Konate I; Weiss HA; Defer MC; Foulongne V; Sanon A; Andonaba JB; Segondy M; Mayaud P; Van de Perre P
    AIDS; 2006 Nov; 20(18):2305-13. PubMed ID: 17117016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa.
    Delany S; Mlaba N; Clayton T; Akpomiemie G; Capovilla A; Legoff J; Belec L; Stevens W; Rees H; Mayaud P
    AIDS; 2009 Feb; 23(4):461-9. PubMed ID: 19155993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
    Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
    J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical Genital Herpes Shedding in HIV/Herpes Simplex Virus 2-Coinfected Women during Antiretroviral Therapy Is Associated with an Increase in HIV Tissue Reservoirs and Potentially Promotes HIV Evolution.
    Stinn T; Kuntz S; Varon D; Huang ML; Selke S; Njikan S; Ford ES; Dragavon J; Coombs RW; Johnston C; Bull ME
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33028713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women.
    Mayaud P; Nagot N; Konaté I; Ouedraogo A; Weiss HA; Foulongne V; Defer MC; Sawadogo A; Segondy M; Van de Perre P;
    Sex Transm Infect; 2008 Oct; 84(5):332-7. PubMed ID: 18596069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women.
    Augenbraun M; Corey L; Reichelderfer P; Wright DJ; Burns D; Koelle DM; Robison E; Cohen M;
    Clin Infect Dis; 2001 Sep; 33(6):885-90. PubMed ID: 11512094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care seeking among men with genital ulcer disease in South Africa: correlates and relationship to human immunodeficiency virus-1 and herpes simplex virus type 2 detection and shedding.
    Leichliter JS; Lewis DA; Sternberg M; Habel MA; Paz-Bailey G
    Sex Transm Dis; 2011 Sep; 38(9):865-70. PubMed ID: 21844743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of genital shedding of herpes simplex virus type 2 and HIV-1 among sex workers in rural Zimbabwe.
    Cowan FF; Pascoe SJ; Barlow KL; Langhaug LF; Jaffar S; Hargrove JW; Robinson NJ; Latif AS; Bassett MT; Wilson D; Brown DW; Hayes RJ
    AIDS; 2006 Jan; 20(2):261-7. PubMed ID: 16511420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers.
    Cowan FM; Pascoe SJ; Barlow KL; Langhaug LF; Jaffar S; Hargrove JW; Robinson NJ; Bassett MT; Wilson D; Brown DW; Hayes RJ
    Sex Transm Infect; 2008 Dec; 84(7):548-53. PubMed ID: 18684855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient Increase in Herpes Simplex Virus Type 2 (HSV-2)-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV/HSV-2-Coinfected Individuals.
    Fife KH; Mugwanya K; Thomas KK; Baeten JM; Celum C; Bukusi E; de Bruyn G; Mujugira A; Vwalika B; Wald A; Lingappa JR;
    J Infect Dis; 2016 May; 213(10):1573-8. PubMed ID: 26704611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology of genital ulcer disease and association with human immunodeficiency virus infection in two tanzanian cities.
    Ahmed HJ; Mbwana J; Gunnarsson E; Ahlman K; Guerino C; Svensson LA; Mhalu F; Lagergard T
    Sex Transm Dis; 2003 Feb; 30(2):114-9. PubMed ID: 12567167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.